Unmet Needs in the Treatment of Certain Glomerular Diseases
source: pixabay.com

Unmet Needs in the Treatment of Certain Glomerular Diseases

by Lauren Taylor from In The Cloud Copy Nephrologists worldwide have shown that there is a huge unmet need when it comes to the treatment of various glomerular diseases, in…

Continue Reading Unmet Needs in the Treatment of Certain Glomerular Diseases
Year Two of This Alport Syndrome Trial Concludes with Encouraging Findings
source: pixabay.com

Year Two of This Alport Syndrome Trial Concludes with Encouraging Findings

According to a story from GlobeNewswire, the biopharmaceutical company Reata Pharmaceuticals, Inc., recently announced that year two of its phase 3 clinical trial has been completed. This trial is testing…

Continue Reading Year Two of This Alport Syndrome Trial Concludes with Encouraging Findings
Data from Roxadustat Program for Anemia of CKD Shared at ASN Kidney Week 2020
source: pixabay.com

Data from Roxadustat Program for Anemia of CKD Shared at ASN Kidney Week 2020

In late October, the American Society of Nephrology (ASN) held the ASN Kidney Week 2020 Reimagined. During the conference, biopharmaceutical company FibroGen shared two posters (abstracts PO2625 and PO2626) regarding…

Continue Reading Data from Roxadustat Program for Anemia of CKD Shared at ASN Kidney Week 2020
FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment
stevepb / Pixabay

FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment

The FDA has recently granted the Breakthrough Therapy designation to FARXIGA, a chronic kidney disease treatment created by AstraZeneca. This designation will allow for a quicker development, which will hopefully…

Continue Reading FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment
American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign
source: pixabay.com

American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign

According to a press release from the American Kidney Fund (AKF), the organization, which is dedicated to fighting kidney disease, has partnered with the biotech company Sanofi Genzyme in a…

Continue Reading American Kidney Fund and Sanofi Genzyme Partner up for New Fabry Disease Campaign
This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
source: pixabay.com

This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients

Lupus nephritis causes kidney inflammation and can often lead to chronic kidney disease (CKD). An issue that medical professionals have faced is predicting the likelihood of individual patients developing CKD.…

Continue Reading This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available
source: pixabay.com

Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

According to a story from Physician's Weekly, while measuring the concentration of albumin (albuminuria) is widely considered the standard method for staging and screening for chronic kidney disease, a different…

Continue Reading Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

High ROBO2 Protein Levels in Chronic Kidney Disease Point to a New Therapeutic Target

  According to a recent article in EurekaAlert, researchers at the University of Boston recently published their new study investigating ROBO2. The ROBO2 signaling pathway has emerged as a therapeutic…

Continue Reading High ROBO2 Protein Levels in Chronic Kidney Disease Point to a New Therapeutic Target
An Experimental Treatment for Primary Hyperoxaluria has Earned Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Treatment for Primary Hyperoxaluria has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the biopharmaceutical company Dicerna Therapeutics, Inc. has announced recently that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to…

Continue Reading An Experimental Treatment for Primary Hyperoxaluria has Earned Rare Pediatric Disease Designation
Is There Too Much Variability in Hyperkalemia Management?
Photo by Robina Weermeijer on Unsplash

Is There Too Much Variability in Hyperkalemia Management?

  The virtually-held National Kidney Foundation 2020 Spring Clinical Meetings explored various topics relating to nephrological conditions, treatment, and patient outcomes. One presentation, spearheaded by Dr. Adam Weinstein, MD, and…

Continue Reading Is There Too Much Variability in Hyperkalemia Management?
New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits
source: pixabay.com

New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits

Ocala Fire Rescue Department (OFD) has just launched a "community paramedicine program." The primary aim of this new program is to help keep patients who frequently call 911 out of…

Continue Reading New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits
Korsuva Given Breakthrough Therapy Indication, Treats Itching from Chronic Kidney Disease
pixabay.com

Korsuva Given Breakthrough Therapy Indication, Treats Itching from Chronic Kidney Disease

According to a news release from Biospace, recent data from the KALM-2 Phase III trial highlighted how Korsuva, an injectable, is beneficial in treating severe itching associated with severe chronic…

Continue Reading Korsuva Given Breakthrough Therapy Indication, Treats Itching from Chronic Kidney Disease